Tumor marker and application thereof
AssigneeShanghai Epiprobe Biotechnology Co., Ltd.
InventorsShihua DONG, Zhenyan LI
Life of this patent
Estimating the term…
Loading patent…
AssigneeShanghai Epiprobe Biotechnology Co., Ltd.
InventorsShihua DONG, Zhenyan LI
Estimating the term…
The present invention provides a tumor marker and an application thereof. The tumor marker is located on the chromosome 1, chromosome 2, chromosome 3, chromosome 5, chromosome 7, chromosome 8, chromosome 10, chromosome 11, and chromosome 21 of the human genome, and comprises one or more CpG sites capable of undergoing methylation modification. The present invention provides a class of DNA epigenetic modification-related tumor markers that exhibit a significant high methylation status in tumor patients. The tumor markers can be used for clinical assisted screening, diagnosis, prognosis and the like of tumors, or can be used for designing diagnostic reagents and kits.
A tumor marker, wherein, the tumor marker is located on the chromosome 1, chromosome 2, chromosome 3, chromosome 5, chromosome 7, chromosome 8, chromosome 10, chromosome 11, and chromosome 21 of the human genome, and comprises one or more CpG sites can be subject to methylation modification.
Dependencies are inferred from the claim text.